Tesavel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tesavel, covering 2025-12-01 to 2025-12-01. Get the full timeline:
Most recent: EMA Authorised: Tesavel (sitagliptin) — Merck Sharp & Dohme B.V.
1 regulatory and trial event tracked for Tesavel, covering 2025-12-01 to 2025-12-01. Get the full timeline:
Most recent: EMA Authorised: Tesavel (sitagliptin) — Merck Sharp & Dohme B.V.